Whitehawk Therapeutics Inc (WHWK) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access WHWK Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Whitehawk Therapeutics Inc's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent34.79
Short-term Investments, Total88.25
Cash & Short-term Investments122.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.51
Total Current Assets125.55
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent1.68
Total Assets127.23
Liabilities
Accounts Payable, Current AC1.75
Accrued Liabilities, Current AC9.31
Total Current Liabilities11.06
Total Long-term Debt0.00
Total Liabilities11.06
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock491.63
Retained Earnings / Accumulated Deficit-375.44
Other Equity-0.01
Common Stockholder's Equity116.18
Total Stockholder's Equity116.18
Liabilities & Stockholder's Equity127.23
4 historic quarters locked

Sign in to unlock the full Whitehawk Therapeutics Inc balance sheet history.

About Whitehawk Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-337933

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.